Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Cash from Investing Activities (2018 - 2025)

Entera Bio has reported Cash from Investing Activities over the past 8 years, most recently at -$27000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 800.0% year-over-year to -$27000.0, compared with a TTM value of -$107000.0 through Dec 2025, down 3466.67%, and an annual FY2025 reading of -$107000.0, down 3466.67% over the prior year.
  • Cash from Investing Activities came in at -$27000.0 for Q4 2025, up from -$43000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$1000.0 in Q2 2023 to a low of -$57000.0 in Q3 2022.
  • Median Cash from Investing Activities over the past 5 years was -$10500.0 (2021), compared with a mean of -$17571.4.
  • The sharpest move saw Cash from Investing Activities skyrocketed 94.74% in 2023, then tumbled 800.0% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$10000.0 in 2021, then surged by 70.0% to -$3000.0 in 2022, then plummeted by 66.67% to -$5000.0 in 2023, then skyrocketed by 40.0% to -$3000.0 in 2024, then tumbled by 800.0% to -$27000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Cash from Investing Activities are -$27000.0 (Q4 2025), -$43000.0 (Q3 2025), and -$29000.0 (Q2 2025).